BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8801744)

  • 1. [Effectiveness of free and liposomal forms of platinum and anthracycline antibiotics for hepatic metastasis of GA-1 and P-388 tumors in mice].
    Kaledin VI; Il'nitskaia SI
    Vopr Onkol; 1996; 42(3):64-6. PubMed ID: 8801744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthracycline antibiotics with high liposome entrapment: structural features and biological activity.
    Perez-Soler R; Priebe W
    Cancer Res; 1990 Jul; 50(14):4260-6. PubMed ID: 2194651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of adriamycin against a liver metastatic model by encapsulation in liposomes.
    Yachi K; Suzuki N; Tanaka N; Okada K; Mitsui I; Kawato Y; Komagata Y; Komiyama K; Kikuchi H
    Biopharm Drug Dispos; 1996 Nov; 17(8):699-715. PubMed ID: 8950048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of cycloplatam in the free form and included in liposomes during metastasis of GA-1 tumors in A/He mice].
    Kaledin VI; Chel'tsov PA
    Eksp Onkol; 1989; 11(5):74-7. PubMed ID: 2791961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties.
    Zou Y; Ling YH; Van NT; Priebe W; Perez-Soler R
    Cancer Res; 1994 Mar; 54(6):1479-84. PubMed ID: 8137251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Joint therapy of experimental tumors with diazan in combination with antibiotics].
    Volkova LM; D'iachkovskaia RF; Konovalova NP
    Antibiotiki; 1979 Apr; 24(4):300-3. PubMed ID: 87148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological, toxicological, and therapeutic evaluation in mice of doxorubicin entrapped in cardiolipin liposomes.
    Rahman A; White G; More N; Schein PS
    Cancer Res; 1985 Feb; 45(2):796-803. PubMed ID: 3967247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of tumor-associated macrophages in the delivery of liposomal doxorubicin to solid murine fibrosarcoma tumors.
    Mayer LD; Dougherty G; Harasym TO; Bally MB
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1406-14. PubMed ID: 9067330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Liposomal forms of cytostatics in oncology].
    Krasnopol'skiĭ IuM; Dranov AL; Stepanov AE; Shvets VI
    Vestn Ross Akad Med Nauk; 1998; (5):35-40. PubMed ID: 9662995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver metastases from colorectal cancer: drug delivery with liposome-encapsulated doxorubicin.
    Cay O; Kruskal JB; Nasser I; Thomas P; Clouse ME
    Radiology; 1997 Oct; 205(1):95-101. PubMed ID: 9314969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model.
    Saucier JM; Yu J; Gaikwad A; Coleman RL; Wolf JK; Smith JA
    J Oncol Pharm Pract; 2007 Mar; 13(1):39-45. PubMed ID: 17621566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular targeting of doxorubicin using cationic liposomes.
    Wu J; Lee A; Lu Y; Lee RJ
    Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of the antitumor activity of free doxorubicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma model.
    Cabanes A; Tzemach D; Goren D; Horowitz AT; Gabizon A
    Clin Cancer Res; 1998 Feb; 4(2):499-505. PubMed ID: 9516942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I clinical trial of liposomal daunorubicin in hepatocellular carcinoma complicating liver cirrhosis.
    Daniele B; De Vivo R; Perrone F; Lastoria S; Tambaro R; Izzo F; Fiore F; Vallone P; Pignata S
    Anticancer Res; 2000; 20(2B):1249-51. PubMed ID: 10810429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The cross resistance to cytostatics of leukemia P388 cells with induced resistance to doxorubicin].
    Donenko FV; Sitdikova SM; Kabieva AO
    Biull Eksp Biol Med; 1993 Sep; 116(9):309-11. PubMed ID: 8118011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal anthracyclines.
    Gabizon AA
    Hematol Oncol Clin North Am; 1994 Apr; 8(2):431-50. PubMed ID: 8040147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of liposomal forms of cytostatics].
    Dranov AL; Dudnichenko AS; Mezin IA; Menzeleev RF; Krasnopol'skiĭ IuM; Shvets VI
    Biull Eksp Biol Med; 1996 Jan; 121(1):85-8. PubMed ID: 8680014
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
    Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
    Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
    Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
    Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.